At the time of writing, Catheter Precision Inc [VTAK] stock is trading at $0.38, up 13.54%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The VTAK shares have gain 14.32% over the last week, with a monthly amount drifted -1.42%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Catheter Precision Inc [AMEX: VTAK] stock has seen the most recent analyst activity on August 13, 2019, when Piper Jaffray downgraded its rating to a Neutral and also revised its price target to $1.50 from $9. Previously, Maxim Group started tracking the stock with Buy rating on November 02, 2018, and set its price target to $23.
For the past year, the stock price of Catheter Precision Inc fluctuated between $0.30 and $8.40. Catheter Precision Inc [AMEX: VTAK] shares were valued at $0.38 at the most recent close of the market.
Analyzing the VTAK fundamentals
According to Catheter Precision Inc [AMEX:VTAK], the company’s sales were 0.40M for trailing twelve months, which represents an -27.82% plunge. Gross Profit Margin for this corporation currently stands at 0.9% with Operating Profit Margin at -27.04%, Pretax Profit Margin comes in at -29.28%, and Net Profit Margin reading is -29.28%. To continue investigating profitability, this company’s Return on Assets is posted at -0.44, Equity is -0.7 and Total Capital is -0.45. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.15.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.3213 points at the first support level, and at 0.2612 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.4283, and for the 2nd resistance point, it is at 0.4752.
Ratios To Look Out For
It is important to note that Catheter Precision Inc [AMEX:VTAK] has a current ratio of 0.66. As well, the Quick Ratio is 0.65, while the Cash Ratio is 0.49. Considering the valuation of this stock, the price to sales ratio is 7.62, the price to book ratio is 0.10.
Transactions by insiders
Recent insider trading involved COLOMBATTO MARTIN J, Director, that happened on Jan 29 ’25 when 3.0 shares were sold.
